CiDA 2018  | NOVEMBER 1-2, 2018

SoDA 2018 | OCTOBER 31, 2018

The Marriott Marquis, Washington, D.C.

JOIN MAILING LIST

2018 Scientific Program

THURSDAY NOVEMBER 1, 2018        FRIDAY, NOVEMBER 2, 2018


VIEW LECTURE SLIDES


 
WedneSDAY, OCTOBER 31, 2018

VIEW SoDA Program

 

THURSDAY, NOVEMBER 1, 2018

6:30 a.m.
Registration, Continental Breakfast and Industry Session
 
7:30 a.m.Welcome and Introduction: The Future of Renal Replacement
 

 

 
 

Session #1: Incidence, Prevalence and Trends in Renal Replacement

 
7:40 a.m.Report from India
7:47 a.m.Report from USA
7:54 a.m.Report from Scandinavia
8:01 a.m.

Panel Discussion

 
 

 

 
 

Debate #1: Renal Replacement: To Live or Let Die?

 
8:15 a.m.Our Society Cannot Afford Renal Replacement for Everyone
8:20 a.m.Is Comprehensive ESRD Care the Responsibility of a Society?

8:25 a.m.

Panel Discussion: Patient's Responsibility 
 

 

 
 

Session #2: Can We Afford to Improve Dialysis Access Care?


8:35 a.m.How the FDA Approaches Review of Disruptive Technology
8:42 a.m.The CMS Approach to Dialysis Access Maintenance: Shaping the Future of Care
8:49 a.m.The Realities of Running a Clinically Successful Out-of-Hospital Practice
9:06 a.m.How Doctors Should be Paid: Pay-for-Procedure? Pay-for-Performance?
9:13 a.m.Panel Discussion: Time to Get Out of the ESRD Business? 
 

 

 
 

Debate #2: Stent-grafts and DCB’s: Affordable?


9:20 a.m.New, Effective and Unaffordable
 
9:25 a.m.New, Effective and Will Reduce the Total Cost of Care 

9:30 a.m.

Panel Discussion: Can Better but Costlier Care be Provided in a Fee-for-Service Reimbursement System? 
 

 

 
 

Case #1: Follow Up from Cases at 2017 CiDA (As Promised!)


9:40 a.m.

Panel Discussion and Audience Participation 
10:00 a.m.Refreshment Break With the Exhibitors 
 

 

 
 

Session #3: AV Access Maintenance Clinical Trial Updates


10:30 a.m.The LUTONIX AV IDE Trial 
10:37 a.m.The DCB Registry 
10:44 a.m.IN.PACT Trial
 
10:51 a.m.AVeVA Trial 12-month and AVeNEW Trial First Look 
10:58 a.m.Stem Cells for Preventing Vascular Injury in AVF: From Bench to Bedside 
11:05 a.m.Phase 3 Study of Vonapanitase in Radiocephalic AVF’s: 600 Patients Later 
11:12 a.m.Panel Discussion: Which Innovations Will Matter the Most? 
 

 

 
 

Case #2: AVF Stenosis. Now What?

 
11:22 a.m.Panel Discussion and Audience Participation 
12:00 p.m.Lunch and Industry Sessions 
 

 

 
 

Session #4: Creating Useful, Mature and Useable AV Fistulae

 
1:30 p.m.Timing of Pre-emptive AVF and the Kidney Failure Risk Equation (KFRE):  What You Can Tell Your Patients Today 
1:37 p.m.The DAC AVF Immaturity Study. What is “Immaturity” and What Are Its Causes? 
1:44 p.m.Five Things Surgeons Should NEVER Do When Creating an AVF 
1:51 p.m.Five Things Surgeons Should ALWAYS Do When Creating an AVF 
1:58 p.m.Panel Discussion: Get it Right the First Time 
   
 Case #3: AVF Creation Based Upon the Kidney Failure Risk Equation (KFRE) 
2:06 p.m.

Panel Discussion and Audience Participation

 
   
 

Session #5: Lumen versus Lesion: What Are We Treating?

2:26 p.m.Histology of AVF Stenosis and Implications for Treatment 
2:33 p.m.Late Breaking Lecture 
   
 Debate #3: Tissue Characteristic of an AVF Stenosis
2:40 p.m.The Issue is Tissue and the Solution to Creating and Maintaining Long Lasting AV Access is On the Cellular Level 
2:45 p.m.Cellular? In Our Lifetime? Stent Grafts and DCB’s Are Here Now 
2:50 p.m.Panel Discussion:  Today, Tomorrow and Beyond  
3:00 p.m.Refreshment Break with Exhibitors

 

 

Session #6: Renal Transplantation and Peritoneal Dialysis

3:30 p.m.Current State of Cadaveric Donor Transplantation 
3:37 p.m.
Living Related Transplantation: An Update 
3:44 p.m.Peritoneal Dialysis: An Update 
3:51 p.m.Failure Modes of Peritoneal Dialysis 
3:58 p.m.Panel Discussion: PD or HD…What Would You Choose for Yourself?
   
 Case #4: Catheter Capers
4:08 p.m.

Panel Discussion and Audience Participation

   
4:30 p.m.It’s Access Academic
 Team 1:
 
 Team 2:
 
 Team 3:
 
   
5:30 p.m.ADJOURN DAY #1 

 

Friday, November 2, 2018

 
 "The Computer Will See You Now” - The Future of Medicine?
 
 Session #7: Decisions that Guide Optimal Outcomes
8:00 a.m.INTRO: 300 Access Options - Too Much for the Human Brain 
8:10 a.m.

C-communication-IQ in a Complex System

 
8:17 a.m.The Computer Will See You Now: Meet Your New Boss – Mr. Algorithm 
   
 Debate #4: How to Achieve the Best Outcomes When Creating Dialysis Access
8:24 a.m.An Experienced Physician is a Far Better Decision Maker Than Any Algorithm 
8:29 a.m.Best Decisions are Based Upon Data and Analytics That Can Be Used to Create Algorithms for Optimal Care 
8:34 a.m.Panel Discussion: Are We Smarter Than the Computer or Too Dumb to Realize We Aren’t?
   
8:44 a.m.
You Arrived Alive to DC: What Healthcare Can Learn from Aviation 
8:51 a.m.Panel Discussion: Are YOU Safe at Work? Ready for the “Black Box” in the OR? 
   
 Session #8: Thou Shall Not Steal
9:01 a.m.Algorithms for Distal Hypo-perfusion (DASS) 
 

 

 
 

Case #5: Steal

9:08 a.m.Panel Discussion
 

 

 
 

Session #9: AV Access Creation Clinical Trial Updates

 
9:30 a.m.HUMANITY Trial Update 
9:37 a.m.SAVE-US Pivotal Trial and European Experience Updates 
9:44 a.m.EndoAVF: Update from European Experience and US Trial Data 
9:52 a.m.tRAD AVF: ELLIPSYS Trial Results Update
10:00 a.m.

Refreshment Break with the Exhibitors

 
 

 

 

Case #6: EndoAVF Creation LIVE Cases

10:30 a.m.

1st Case:  10:30-10:50 (20 min)

2nd Case:  10:50-11:10 (20 min)

   
 

Session #10: Thoracic Central Vein Obstruction (TCVO): “Deep Dive” into the Dark Blue Pool

 
11:10 a.m.Finally, the SIR TCVO Reporting Standards are Here. What You Should Know 
11:17 a.m.Bare Metal Stents for TCVO: RIP…or Not? 
11:24 a.m.Drug Coated Balloons for TCVO: Any Signal That This Works? 
11:31 a.m.The Role for Stent-Grafts for TCVO: What We’ve Learned So Far
11:38 a.m.

Surgery for Symptomatic TCVO: Flow Reduction, Graft Catheters and more

 
11:46 a.m.

Panel Discussion: TCVO – An Unmet Need

 
12:00 p.m.

Lunch and Industry Sessions

 
 

 

 
1:30 p.m.Concurrent Clinic Session 
 Clinic A
 Peritoneal Dialysis
   
 Clinic B
 Thoracic Central Vein Obstruction
   
 Clinic C
 The Clotted AV Access
2:30 p.m.

Refreshment Break with the Exhibitors

 
   
3:00 p.m.

Keynote Lectures: Did You Mean What You Said and Said What You Meant?

Communication IQ. Do You Have It and Can It Be Learned?

3:15 p.m.

Keynote Lectures: Did You Mean What You Said and Said What You Meant?

Avoiding Disaster: What is Aviation Doing So Right? What Can It Do Better?

   
 CASE #7: Cases Now for Follow Up Next Year
3:30 p.m.Panel Discussion and Audience Participation 
3:55 p.m. _____________Concluding Remarks from CiDA 2018